Molecular Residue Cancer Detection - Dr. Nate Montgomery

About this episode

This episode discusses advancements in molecular technologies for early cancer detection and treatment monitoring.

This episode explores the latest advancements in personalized DNA and RNA technologies for early cancer detection, diagnostics, and treatment monitoring. New technologies identify molecular signatures of tumors that help predict onset and re-occurrence of disease. Dr. Nathan Montgomery from Neo Genomics Laboratories discusses how molecular residual disease testing, liquid biopsies, and genomic sequencing are transforming oncology care.

People in this episode

Host: Dr. Kevin Folta

Guest: Dr. Nate Montgomery

Topics covered

• cancer detection
• DNA technologies
• RNA technologies
• liquid biopsies
• genomic sequencing
• oncology care

Keywords

• molecular residual disease
• cancer detection
• liquid biopsies
• genomic sequencing
• tumor signatures

Mentioned in this episode

Organizations: Neo Genomics Laboratories

More episodes of Talking Biotech with Dr. Kevin Folta

• Milk Proteins without the Dairy - Adam Tarshis and Dr. Cory Tobin · June 9, 2026 · 48 min
• New Technology in Severe Burn Care - Dr. Katie Bush · June 1, 2026 · 29 min
• Strategies in Combating Chronic Kidney Disease - Dr. Salvatore Viscomi · May 17, 2026 · 38 min
• AI and the Future of Healthcare -- Dr. Emilia Javorsky · May 8, 2026 · 39 min
• The First Environmental GE Organism Release - almost! Dr. Steven Lindow · April 28, 2026 · 26 min
• New Frontiers in Therapeutic Peptides - Dr. Karsten Eastman · April 16, 2026 · 33 min